At the invitation of Buenos Aires Mayor, Mr. Jorge Macri, and the Minister of Health of the Province of Buenos Aires, Dr. Andrés Scarsi, MD, Dr. Low delivers keynote at Argentina's One Health conference.

Argentina Dr.Low

November 24th, 2018 - Buenos Aires, Argentina





Wyoming and NeuroVigil sign Memorandum of Understanding

September 20th,h 2018 - Jackson Hole, Wyoming, USAWyoming Seal Gold

 Dr. Low delivers Oxford Inspires keynote address: "From Gaddafi's oil to Hawking's Brain".

Oxford University Logo

July 14th, 2018 - Saïd Business School, Oxford University, UK




November 15th, 2017 - Forbes.comEurotox Bratislava

September 10th, 2017 - Slovak National Theatre, Bratislava, SVK


Dr. Low is Keynote Speaker at NeuroTech NYC

June 8th, 2016 - New York City, NYnyc jun716

Dr. Low keynotes San Francisco AI conference

May 25th, 2016 - San Francisco, CA

Dr. Low is Keynote Speaker at Neurotech SF

April 6th, 2016 - San Francisco, CA

Neurotech SF

Neurotech Goes Global: Tens of Thousands of Brains Coming Online

February 4th, 2015 - medGadget





Dr. Low is Keynote Speaker at II International Conference of Alternatives to Animal Experimentation

May 8th-9th, 2015 - Portugal
Screen Shot 2014-12-22 at 11.37.11 AM




Dr. Low to speak at The Harvard Animal Consciousness Symposium:

"The Cambridge Declaration on Consciousness: Causes and Consequences" 

November 15th-16th, 2014, Cambridge, MA 

Harvard Wreath Logo 1 svg






Dr. Low to present at METal International: "Unmasking the Brain's Dark Matter"  

 October 4th, 2014 - Los Angeles, CA
2604046 300x300





NeuroVigil Announces New Brain Research Initiatives

August 14th, 2014 - MarketWatch





Dr. Low to address III Brazilian Congress on Bioethics and Animal Welfare               

August 5th, 2014 - Curitiba, BrazilCongresso-Brasileiro-de-bioetica-e-bem-estar-animal



The Cambridge Declaration on Consciousness

July 7th, 2014 - New York Times NYT1

"If you ask my colleagues whether animals have emotions and thoughts,” says Philip Low, a prominent computational neuroscientist, “many will drop their voices to a whisper or simply change the subject. They don’t want to touch it.” Jaak Panksepp, a professor at Washington State University, has studied the emotional responses of rats. “Once, not very long ago,” he said, “you couldn’t even talk about these things with colleagues... In the summer of 2012, an unprecedented document, masterminded by Low — “The Cambridge Declaration on Consciousness in Human and Nonhuman Animals” — was signed by a group of leading animal researchers in the presence of Stephen Hawking. It asserted that mammals, birds and other creatures like octopuses possess consciousness and, in all likelihood, emotions and self-awareness... “Afterward, an eminent neuroanatomist came up to me and said, ‘We were all thinking this, but were afraid to say it,’ ”Low recalled... For Philip Low, the Cambridge Declaration was aimed directly at the Cartesian prejudice against nonhumans. “The term ‘animal’ is simply an excuse not to look at something,” Low argues, citing eugenics, phrenology and 'scientific' racism as byproducts of the tendency to elevate humans — especially certain humans — over other beings.


Dr. Low Presented at Future In Review Conference

May 22nd, 2014 - Montage Hotel, Laguna Beach, CA


Dr. Low Bio





Dr. Low to Present at NASA Research Park Exploration Lecture Series

April 2nd, 2014 - NASA Ames Research Center, Mountain View, CAnasa logo

The event is free and open to the public.  For more information, please visit:


Presentation Flyer


Dr. Philip Low Speaker Bio



NeuroVigil CEO to Speak at Inaugural FED Talk at Jewish Federation

March 20th, 2014 - San Diego, CA
FedTalks Header

For more information, please visit:

FedTalks - Brilliant Minds. Powerful Ideas.
San Diego Jewish World




Congressman Fattah's reaction to Dr. Low's keynote at Israel's first International Brain Technology Conference

October 17th, 2013 - United States Congress

Fattah who spoke earlier in the conference, praised Dr. Low's breakthrough research and his commitment to the millions of patients in America, and worldwide, that suffer from brain diseases and disorders. 
"Dr. Low is doing truly remarkable work within the neuroscience field and I am thrilled we could partner to bring this future round of clinical trials to Philadelphia," Fattah said.